Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Skin health and diseases are closely linked to metabolic processes.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Multiple treatments work best for hair loss.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.